AMENDMENT NO. 3 TO CONSULTING AGREEMENTConsulting Agreement • July 19th, 2024 • Pulmatrix, Inc. • Pharmaceutical preparations
This Amendment No. 3 to Consulting Agreement (this “Amendment No. 3”) is made effective as of July 20, 2024, by and between Pulmatrix, Inc., a Delaware corporation, with its principal place of business being 945 Concord Street, Suite 1217, Framingham, MA 01701 (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability company, with a principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). Capitalized terms used but not defined herein shall have the respective meaning set forth in the Consulting Agreement by and between Danforth and the Company dated as of November 29, 2021, as may be amended from time to time (the “Agreement”).
GENERAL RELEASE AND SEVERANCE AGREEMENTGeneral Release and Severance Agreement • July 19th, 2024 • Pulmatrix, Inc. • Pharmaceutical preparations • Massachusetts
This General Release and Severance Agreement (this “Agreement”), dated as of July 19, 2024, is made and entered into by and between Teofilo Raad (“Employee”) and Pulmatrix, Inc. (the “Company”).
